Pharma News Intelligence January 3, 2024
Veronica Salib

Reuters broke the news that the approximately 500 drugs in the US are supposed to increase in January 2024.

Last week, just before the end of 2023, Reuters published an article breaking a story from data analyzed by 3 Axis Advisors, a healthcare research firm. The analysis evaluated anticipated drug price hikes in the coming month, revealing that approximately 500 drugs of varying doses and formulations from over 140 brands are expected to increase their list prices in January 2023.

For example, Pfizer is projected to have the most significant number of January drug price increases, accounting for 25% of the anticipated increases. Overall, Pfizer intends to increase the cost of 124 drugs and 22 additional drugs through Hospira.

Last...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, CMS, Congress / White House, Govt Agencies, HHS, Insurance, Medicare, Patient / Consumer, Pharma, Pharma / Biotech, Provider
CVS Plans Chain of Smaller-Footprint Pharmacy-Focused Stores
As Walgreens Preps For New Owner, CVS Health Tries Smaller Drugstores
AACR Precision Medicine 2025: AACR Past-President Elaine R. Mardis, PhD, Discusses Highlights of the Meeting for Pharmacists
Anna Greka: Molecular Sleuthing for Rare Diseases
Gene Therapy in an Implant: Neurotech Lands First FDA Approval in Rare Vision Disorder

Share This Article